SQUAMOUS CELL LUNG CANCER
Clinical trials for SQUAMOUS CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients to receive experimental cancer drug in groundbreaking safety trial
Disease control Recruiting nowThis is the first-ever study in people to test a new cancer drug called TT125-802. The main goal is to find a safe dose and check for side effects in 50 adults with advanced solid tumors that have stopped responding to standard treatments. Researchers will also look for early sig…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE1 • Sponsor: TOLREMO therapeutics AG • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
New immune cell therapy tested for Tough-to-Treat lung cancer
Disease control Recruiting nowThis is an early-stage trial testing the safety of a new type of personalized immune cell therapy called C-CAR031. It is for adults with an advanced form of squamous cell lung cancer that has a specific marker (GPC3+) and has stopped responding to up to three prior treatments. Th…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Shanghai AbelZeta Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Targeted drug trial aims to slow Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is testing if the experimental drug ZEN003694 can help control advanced squamous cell lung cancer in people whose cancer has a specific genetic change called NSD3 amplification. The drug works by blocking certain proteins that cancer cells may need to grow. Researchers…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC